"As a pioneer and a leader in the field of surgical guidance systems, Mazor Robotics saw two significant milestones in 2016: the launch of our strategic partnership with Medtronic followed by the commercial release of the new Mazor X™. We are very excited to see what 2017 brings for our company," says: Christopher Prentice, CEO Mazor Robotics, Inc.
Since signing the agreement in May 2016, Mazor and Medtronic have invested in co-marketing, promotion, and training efforts towards commercialization of Mazor X™, a transformative platform for spine procedures that launched in October at the North American Spine Society (NASS) Annual Meeting. Between the two companies, there are now hundreds of highly experienced capital and clinical specialists responsible for raising the awareness of, selling and supporting Mazor X.
- Mazor Robotics Signs Strategic Commercial and Investment Agreements with Medtronic, a Global Leader in Spine Technologies and Solutions
- Mazor Robotics Commercially Launches Mazor X at the North American Spine Society (NASS) Annual Meeting
- Mazor Robotics Received Purchase Orders for 21 Systems During Fourth Quarter 2016; Full Year System Orders Increased by 138% to All Time Record of 62 Units
Mazor Robotics (TASE: MZOR; NASDAQ-GM: MZOR) believes in healing through innovation by developing and introducing revolutionary technology and products aimed at redefining the gold standard of quality care. Mazor Robotics Guidance Systems enable surgeons to conduct spine and brain procedures in a more accurate and secure manner. For more information, please visit www.MazorRobotics.com.
To view the original version on PR Newswire, visit: http://www.prnewswire.com/news-releases/mazor-robotics-and-medtronic-combine-efforts-on-the-commercialization-of-mazor-x-an-innovative-guidance-system-for-spine-surgery-300425602.html
SOURCE Mazor Robotics Ltd.
|Mazor Robotics Ltd.
Paula Wyatt - Email Contact - 321-946-6565